As part of our commitment to meeting your needs, we can provide you with specialty medications.
Some of these medications are only available through a limited distribution network and often require special handling, such as refrigeration, time-sensitive delivery or special patient instructions.
Foundation Care ensures that you will receive your specialty medications when and where you need them. Our Reimbursement Specialists will work to keep your out-of-pocket costs to a minimum.
- Bethkis® (tobramycin inhalation solution)
- TOBI® (tobramycin inhalation solution)
- TOBI® Podhaler™ (tobramycin inhalation powder)
*View the instructional video by clicking here.
Many compounded antibiotics are available at Foundation Care that are not available at other pharmacies. FC has the resources to provide you with customized medications to aid in preventing infections. To view a complete list, please visit our Compounding Services page by clicking here.
Foundation Care understands the unique needs of the CFRD patient. Because we specialize in CF care, our pharmacists and staff are highly qualified to help care for and educate patients with CFRD.
Foundation Care offers a complete line of diabetes drugs, devices, and supplies. We also participate in programs with diabetic suppliers such as:
KALYDECO is used to treat patients with specific gene mutations in CF, including: G551D, G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D. It works to restore proper function to the CFTR protein.
ORKAMBI is used for the treatment of cystic fibrosis (CF) in patients age 2 years and older who have two copies of the F508del mutation (F508del/F508del) in their CFTR gene. It works to restore proper function to the CFTR protein.
SYMDEKO is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients aged 6-11 and 12 years and older who have two copies of the F508del mutation, or who have at least one mutation in the CF gene that is responsive to treatment with SYMDEKO.
TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is a breakthrough prescription medicine that has demonstrated significant improvements in lung function, with potential to treat the underlying cause of CF in a large majority of patients. TRIKAFTA is approved for patients 12 years and older with CF who have at least one F508del mutation in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, estimated to affect 90 percent of the CF population.
Foundation Care is one of Vertex Pharmaceuticals’ selected partners in providing these drugs.
- Sinus Rinse™ Extra Strength Hypertonic Packets
- Sinus Rinse™ Nasal Rinse Kit
- Compounded Nasal & Sinus Medications
Nasal & Sinus Medication Delivery Devices
Foundation Care is a licensed provider and distributor of top quality nasal and sinus medication delivery devices. These devices are drug delivery systems for the sinonasal region and are clinically-shown to deposit medication throughout the nasal and paranasal sinus cavities. They include:
- Creon® (pancrelipase)
- Pancreas® (pancrelipase)
- Pertzye™ (pancrelipase)
- Viokace™ (pancrelipase)
- Zenpep® (pancrelipase)
- AquADEKs® (multivitamin supplement)
- ChoiceFul Vitamins (multivitamin supplement)
- Replesta™ (cholecalciferol)
Nutritional Drink Supplements
For more information on how to order these products, please call Foundation Care at 877.291.1122.